FDA authorizes Pfizer booster shots for seniors and high-risk individuals

Pfizer vaccine doses.
(Image credit: Sean Gallup/Getty Images)

The Food and Drug Administration on Wednesday authorized booster doses of Pfizer's COVID-19 vaccine for Americans 65 and older and two other groups: younger people with underlying health conditions and those whose jobs put them at high risk of getting the virus.

Now, the Centers for Disease Control and Prevention must come up with its own recommendation on booster shots and when people should get them. A panel of CDC advisers convened on Wednesday to discuss the matter, and some suggested waiting a month and seeing what new evidence might come out about booster shots, The Associated Press reports.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Catherine Garcia, The Week US

Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.